The HealthTech Signal

Market map

Pharma & Drug Discovery

The pharma and drug discovery sector is rapidly evolving as advanced computation and artificial intelligence redefine traditional research methodologies, driving significant public market listings and robust private funding rounds for platforms accelerating therapeutic pipeline development.

52 companies, 32 sub-segments, from our own research

The desk's read

  • AI drug discovery is highly crowded, featuring numerous prominent players like Recursion, Exscientia, and Insilico Medicine that dominate the market space with scaled computational platforms.

  • Niche sub-segments such as literature search and translational prediction remain sparsely populated, with single representatives like Causaly and VeriSIM Life leading these specialized functional areas.

  • Capital heavily concentrates in established AI drug discovery and structure-based design giants, with Recursion and Relay Therapeutics commanding the largest funding pools in the ecosystem.

  • Buyers should watch emerging series-stage innovators in clinical trial design and simulation, as platforms like Unlearn.AI and InSilicoTrials modernize the late-stage drug development pipeline.

AI drug discovery

17

Protein design

5

Structure based design

1

Computational chemistry

1

Antibody discovery

1

Natural product discovery

1

AI-designed therapeutics

1

Thyroid eye disease

1

Protein degradation

1

Clinical trial design

1

Kidney gene therapy

1

Rare disease therapies

1

Literature search and synthesis

1

Cell therapy

1

Protein therapeutics

1

Clinical trial endpoints

1

Translational prediction

1

Synthetic biology

1

Pharmacovigilance AI

1

Biomedical data curation

1

Clinical trial simulation

1

Rare neurology

1

Cardiorenal medicines

1

Targeted oncology

1

Frontier AI

1

Generative biology

1

Rare disease gene therapy

1

Prime editing

1

Rare disease endocrinology

1

AI-native FDA regulatory services

1

Human skin models and AI discovery

1

Neuromuscular and rare diseases

1

Our own research, our own segmentation. Browse every Pharma & Drug Discovery company or open the full database.